Application Notes

Comparison of nanoDSF and µDSC for thermal stability assessment during biopharmaceutical formulation development

Issue link: https://resources.nanotempertech.com/i/1050500

Contents of this Issue

Navigation

Page 2 of 5

3 APPLICATION NOTE ©2017 NanoTemper Technologies, Inc. South San Francisco, CA, USA. All Rights Reserved. presence of polysorbate 20 and 80 (PS20 and PS80, respectively), which are common surfactants for the majority of mAb formulations, but preclude the analysis by orthogonal fl uorescence methods such as DSF assays (will be reported elsewhere). Representative data for the thermal unfolding experiments by µDSC and nanoDSF are shown in Figure 1. For nanoDSF, samples were measured in triplicates, while samples where measured only once with µDSC to save time and sample material. Figure 2: (A) Comparison of T m 1 and T m 2 values determined by nanoDSF (n=3) and µDSC (n=1). nanoDSF data points represent average values. Error bars are smaller than symbol sizes (s.d. <0.1 °C for all measured samples). (B) Comparison of the time- and sample requirements of nanoDSF and µDSC for a formulation screen involving 48 diff erent samples. (C) Summary of benefi ts and limitations of µDSC and nanoDSF for the determination of protein thermal stability. Protein concentration ranges are given for mAb solutions.

Articles in this issue

view archives of Application Notes - Comparison of nanoDSF and µDSC for thermal stability assessment during biopharmaceutical formulation development